Ad hoc announcement pursuant to Art. 53 LR Pratteln, Switzerland, March 4, 2025 - Santhera Pharmaceuticals (SIX: SANN) today provides a trading update for the fiscal year 2024 and an outlook for 2025 ...

Ad hoc announcement pursuant to Art. 53 LR Pratteln, Switzerland, March 4, 2025 – Santhera Pharmaceuticals (SIX: SANN) today provides a trading update for the fiscal year 2024 and an outlook for 2025 ...

1 Day SANN -3.04% DJIA -1.01% Russell 2K -0.91% Health Care/Life Sciences -0.28% ...

Swiss biopharmaceutical company Santhera Pharmaceuticals has named Catherine Isted as its new chief financial officer. She replaces Andrew Smith, who is stepping down after five years and will assist ...

Santhera Pharmaceuticals, a specialty pharmaceutical company focused on rare diseases, announces an agreement with the German National Association of Statutory Health Insurance Funds (GKV-SV) on the ...

Vanessa dos Reis Ferreira is head of Patient Advocacy Europe at Santhera and a rare disease specialist. Here she describes how her company is focused on understanding patient needs to develop ...